AMR supports a global events company in its acquisition of a portfolio of biotech conferences in the US

AMR provided a review of the current performance and future growth potential for the portfolio whilst providing strategic advice on how to reposition an underperforming event to increase its value. AMR identified a geo-cloning opportunity in Europe to extend the growth of the portfolio.

The conferences bring together the leaders in the biotechnology and investment communities to network, exchange ideas and identify new funding opportunities to accelerate the industry’s growth